Skip to main content

Advertisement

Log in

Identification of 9-O-acetyl-N-acetylneuraminic acid (Neu5,9Ac2) as main O-acetylated sialic acid species of GD2 in breast cancer cells

  • Original Article
  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

Mainly restricted to the nervous system in healthy adults, complex gangliosides such as GD3 and GD2 have been shown to be involved in aggressiveness and metastasis of neuro-ectoderm derived tumors such as melanoma and neuroblastoma. Interestingly, O-acetylated forms of GD2, not expressed in human peripheral nerve fibers, are highly expressed in GD2+ tumor cells. Very little information is known regarding the expression of O-acetylated disialogangliosides in breast cancer (BC) cell lines. Here, we analyzed the expression of GD2, GD3 and their O-acetylated forms O-acetyl-GD2 (OAcGD2) and O-acetyl-GD3 (OAcGD3) in BC cells. We used Hs 578T and SUM159PT cell lines, as well as cell clones over-expressing GD3 synthase derived from MDA-MB-231 and MCF-7. Using flow cytometry and immunocytochemistry/confocal microscopy, we report that BC cells express b-series gangliosides GD3 and GD2, as well as significant amounts of OAcGD2. However, OAcGD3 expression was not detected in these cells. O-acetylation of gangliosides isolated from BC cells was examined by LC-MS analysis of sialic acid DMB-derivatives. We report that the main acetylated form of sialic acid expressed in BC gangliosides is 9-O-acetyl-N-acetylneuraminic acid (Neu5,9Ac2). These results highlight a close interrelationship between Neu5,9Ac2 and OAcGD2 expression, and suggest that OAcGD2 is synthetized from GD2 and not from OAcGD3 in BC cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

BC:

Breast Cancer

BSM:

Bovine Submaxillary Mucin

CMP Neu5Ac:

cytidine-monophosphate N-acetylneuraminic acid

DMB:

1,2-diamino-4,5-methylenedioxybenzene

ER:

Estrogen Receptor

Gal:

Galactose

GalNAc:

N-acetylgalacotosamine

GD2S:

GD2 synthase

GD3S:

GD3 synthase

GT:

Glycosyltransferase

HPRT:

Hypoxanthine-guanine PhosphoRibosylTransferase

LacCer:

Lactosyl-ceramide

LC/ESI-MS:

Liquid Chromatography/ Electrospray ionization coupled to Mass Spectrometry

mAb:

monoclonal antibody

MFI:

Mean Fluorescence Intensity

Neu5Ac:

N-acetylneuraminic acid

Neu5,8Ac2 :

8-O-acetyl-N-acetylneuraminic acid

Neu5,9Ac2 :

9-O-acetyl-N-acetylneuraminic acid

OAcGD2:

O-acetyl-GD2

OAcGD3  :

O-acetyl-GD3.

TACA:

Tumor-Associated Carbohydrate Antigens

TNBC:

Triple Negative Breast Cancer

References

  1. Hakomori, S.: Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. Cancer Res. 45(6), 2405–2414 (1985)

    CAS  PubMed  Google Scholar 

  2. Yoshida, S., Fukumoto, S., Kawaguchi, H., Sato, S., Ueda, R., Furukawa, K., Ganglioside, G.: (D2) in small cell lung cancer cell lines: enhancement of cell proliferation and mediation of apoptosis. Cancer Res. 61(10), 4244–4252 (2001)

    CAS  PubMed  Google Scholar 

  3. Yu, A.L., Gilman, A.L., Ozkaynak, M.F., London, W.B., Kreissman, S.G., Chen, H.X., Smith, M., Anderson, B., Villablanca, J.G., Matthay, K.K., Shimada, H., Grupp, S.A., Seeger, R., Reynolds, C.P., Buxton, A., Reisfeld, R.A., Gillies, S.D., Cohn, S.L., Maris, J.M., Sondel, P.M., Children's Oncology, G.: Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N. Engl. J. Med. 363(14), 1324–1334 (2010). https://doi.org/10.1056/NEJMoa0911123

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Dhillon, S.: Dinutuximab: first global approval. Drugs. 75(8), 923–927 (2015). https://doi.org/10.1007/s40265-015-0399-5

    Article  CAS  PubMed  Google Scholar 

  5. Alvarez-Rueda, N., Desselle, A., Cochonneau, D., Chaumette, T., Clemenceau, B., Leprieur, S., Bougras, G., Supiot, S., Mussini, J.M., Barbet, J., Saba, J., Paris, F., Aubry, J., Birkle, S.: A monoclonal antibody to O-acetyl-GD2 ganglioside and not to GD2 shows potent anti-tumor activity without peripheral nervous system cross-reactivity. PLoS One. 6(9), e25220 (2011). https://doi.org/10.1371/journal.pone.0025220

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Malisan, F., Franchi, L., Tomassini, B., Ventura, N., Condo, I., Rippo, M.R., Rufini, A., Liberati, L., Nachtigall, C., Kniep, B., Testi, R.: Acetylation suppresses the proapoptotic activity of GD3 ganglioside. J. Exp. Med. 196(12), 1535–1541 (2002)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Mukherjee, K., Chava, A.K., Mandal, C., Dey, S.N., Kniep, B., Chandra, S., Mandal, C.: O-acetylation of GD3 prevents its apoptotic effect and promotes survival of lymphoblasts in childhood acute lymphoblastic leukaemia. J. Cell. Biochem. 105(3), 724–734 (2008). https://doi.org/10.1002/jcb.21867

    Article  CAS  PubMed  Google Scholar 

  8. Recchi, M.A., Hebbar, M., Hornez, L., Harduin-Lepers, A., Peyrat, J.P., Delannoy, P.: Multiplex reverse transcription polymerase chain reaction assessment of sialyltransferase expression in human breast cancer. Cancer Res. 58(18), 4066–4070 (1998)

    CAS  PubMed  Google Scholar 

  9. Marquina, G., Waki, H., Fernandez, L.E., Kon, K., Carr, A., Valiente, O., Perez, R., Ando, S.: Gangliosides expressed in human breast cancer. Cancer Res. 56(22), 5165–5171 (1996)

    CAS  PubMed  Google Scholar 

  10. Ruckhaberle, E., Karn, T., Rody, A., Hanker, L., Gatje, R., Metzler, D., Holtrich, U., Kaufmann, M.: Gene expression of ceramide kinase, galactosyl ceramide synthase and ganglioside GD3 synthase is associated with prognosis in breast cancer. J. Cancer Res. Clin. Oncol. 135(8), 1005–1013 (2009). https://doi.org/10.1007/s00432-008-0536-6

    Article  CAS  PubMed  Google Scholar 

  11. Cazet, A., Groux-Degroote, S., Teylaert, B., Kwon, K.M., Lehoux, S., Slomianny, C., Kim, C.H., Le Bourhis, X., Delannoy, P.: GD3 synthase overexpression enhances proliferation and migration of MDA-MB-231 breast cancer cells. Biol. Chem. 390(7), 601–609 (2009). https://doi.org/10.1515/BC.2009.054

    Article  CAS  PubMed  Google Scholar 

  12. Cazet, A., Julien, S., Bobowski, M., Krzewinski-Recchi, M.A., Harduin-Lepers, A., Groux-Degroote, S., Delannoy, P.: Consequences of the expression of sialylated antigens in breast cancer. Carbohydr. Res. 345(10), 1377–1383 (2010). https://doi.org/10.1016/j.carres.2010.01.024

    Article  CAS  PubMed  Google Scholar 

  13. Steenackers, A., Vanbeselaere, J., Cazet, A., Bobowski, M., Rombouts, Y., Colomb, F., Le Bourhis, X., Guerardel, Y., Delannoy, P.: Accumulation of unusual gangliosides G(Q3) and G(P3) in breast cancer cells expressing the G(D3) synthase. Molecules. 17(8), 9559–9572 (2012). https://doi.org/10.3390/molecules17089559

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Mandal, C., Schwartz-Albiez, R., Vlasak, R.: Functions and biosynthesis of O-acetylated sialic acids. Top. Curr. Chem. 366, 1–30 (2015). https://doi.org/10.1007/128_2011_310

    Article  CAS  PubMed  Google Scholar 

  15. Baumann, A.M., Bakkers, M.J., Buettner, F.F., Hartmann, M., Grove, M., Langereis, M.A., de Groot, R.J., Muhlenhoff, M.: 9-O-acetylation of sialic acids is catalysed by CASD1 via a covalent acetyl-enzyme intermediate. Nat. Commun. 6(7673), (2015). https://doi.org/10.1038/ncomms8673

  16. Mandal, C., Srinivasan, G.V., Chowdhury, S., Chandra, S., Mandal, C., Schauer, R., Mandal, C.: High level of sialate-O-acetyltransferase activity in lymphoblasts of childhood acute lymphoblastic leukaemia (ALL): enzyme characterization and correlation with disease status. Glycoconj. J. 26(1), 57–73 (2009). https://doi.org/10.1007/s10719-008-9163-3

    Article  CAS  PubMed  Google Scholar 

  17. Ravindranath, M.H., Higa, H.H., Cooper, E.L., Paulson, J.C.: Purification and characterization of an O-acetylsialic acid-specific lectin from a marine crab Cancer antennarius. J. Biol. Chem. 260(15), 8850–8856 (1985)

    CAS  PubMed  Google Scholar 

  18. Sharma, V., Chatterjee, M., Mandal, C., Sen, S., Basu, D.: Rapid diagnosis of Indian visceral leishmaniasis using achatininH, a 9-O-acetylated sialic acid binding lectin. Am J Trop Med Hyg. 58(5), 551–554 (1998)

    Article  CAS  PubMed  Google Scholar 

  19. Zimmer, G., Suguri, T., Reuter, G., Yu, R.K., Schauer, R., Herrler, G.: Modification of sialic acids by 9-O-acetylation is detected in human leucocytes using the lectin property of influenza C virus. Glycobiology. 4(3), 343–349 (1994)

    Article  CAS  PubMed  Google Scholar 

  20. Ravindranaths, M.H., Paulson, J.C., Irie, R.F.: Human melanoma antigen O-acetylated ganglioside GD3 is recognized by Cancer antennarius lectin. J. Biol. Chem. 263(4), 2079–2086 (1988)

    CAS  PubMed  Google Scholar 

  21. Saito, M., Kasai, N.: Yu, R.K.: in situ immunological determination of basic carbohydrate structures of gangliosides on thin-layer plates. Anal. Biochem. 148(1), 54–58 (1985)

    Article  CAS  PubMed  Google Scholar 

  22. Cerato, E., Birkle, S., Portoukalian, J., Mezazigh, A., Chatal, J.F., Aubry, J.: Variable region gene segments of nine monoclonal antibodies specific to disialogangliosides (GD2, GD3) and their O-acetylated derivatives. Hybridoma. 16(4), 307–316 (1997). https://doi.org/10.1089/hyb.1997.16.307

    Article  CAS  PubMed  Google Scholar 

  23. Steenackers, A., Cazet A., Bobowski M., Rombouts Y., Lefebvre J., Guérardel Y., Tulasne D., Le Bourhis X., Delannoy P.: Expression of GD3 synthase modifies ganglioside profile and increases migration of MCF-7 breast cancer cells. C.R. Chimie 15, 3–14 (2012)

  24. Pfaffl, M.W.: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29(9), e45 (2001)

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Klein, A., Diaz, S., Ferreira, I., Lamblin, G., Roussel, P., Manzi, A.E.: New sialic acids from biological sources identified by a comprehensive and sensitive approach: liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS) of SIA quinoxalinones. Glycobiology. 7(3), 421–432 (1997)

    Article  CAS  PubMed  Google Scholar 

  26. Sommer, U., Herscovitz, H., Welty, F.K., Costello, C.E.: LC-MS-based method for the qualitative and quantitative analysis of complex lipid mixtures. J. Lipid Res. 47(4), 804–814 (2006). https://doi.org/10.1194/jlr.M500506-JLR200

    Article  CAS  PubMed  Google Scholar 

  27. Bobowski, M., Vincent, A., Steenackers, A., Colomb, F., Van Seuningen, I., Julien, S., Delannoy, P.: Estradiol represses the G(D3) synthase gene ST8SIA1 expression in human breast cancer cells by preventing NFkappaB binding to ST8SIA1 promoter. PLoS One. 8(4), e62559 (2013). https://doi.org/10.1371/journal.pone.0062559

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Groux-Degroote, S., Guerardel, Y., Delannoy, P.: Gangliosides: structures, biosynthesis, analysis, and roles in Cancer. Chembiochem. 18(13), 1146–1154 (2017). https://doi.org/10.1002/cbic.201600705

    Article  CAS  PubMed  Google Scholar 

  29. Hamamura, K., Furukawa, K., Hayashi, T., Hattori, T., Nakano, J., Nakashima, H., Okuda, T., Mizutani, H., Hattori, H., Ueda, M., Urano, T., Lloyd, K.O., Furukawa, K.: Ganglioside GD3 promotes cell growth and invasion through p130Cas and paxillin in malignant melanoma cells. Proc. Natl. Acad. Sci. U. S. A. 102(31), 11041–11046 (2005). https://doi.org/10.1073/pnas.0503658102

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Cazet, A., Bobowski, M., Rombouts, Y., Lefebvre, J., Steenackers, A., Popa, I., Guerardel, Y., Le Bourhis, X., Tulasne, D., Delannoy, P.: The ganglioside G(D2) induces the constitutive activation of c-met in MDA-MB-231 breast cancer cells expressing the G(D3) synthase. Glycobiology. 22(6), 806–816 (2012). https://doi.org/10.1093/glycob/cws049

    Article  CAS  PubMed  Google Scholar 

  31. Fleurence, J., Cochonneau, D., Fougeray, S., Oliver, L., Geraldo, F., Terme, M., Dorvillius, M., Loussouarn, D., Vallette, F., Paris, F., Birkle, S.: Targeting and killing glioblastoma with monoclonal antibody to O-acetyl GD2 ganglioside. Oncotarget. 7(27), 41172–41185 (2016). https://doi.org/10.18632/oncotarget.9226

    Article  PubMed  PubMed Central  Google Scholar 

  32. Terme, M., Dorvillius, M., Cochonneau, D., Chaumette, T., Xiao, W., Diccianni, M.B., Barbet, J., Yu, A.L., Paris, F., Sorkin, L.S., Birkle, S.: Chimeric antibody c.8B6 to O-acetyl-GD2 mediates the same efficient anti-neuroblastoma effects as therapeutic ch14.18 antibody to GD2 without antibody induced allodynia. PLoS One. 9(2), e87210 (2014). https://doi.org/10.1371/journal.pone.0087210

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Cochonneau, D., Terme, M., Michaud, A., Dorvillius, M., Gautier, N., Frikeche, J., Alvarez-Rueda, N., Bougras, G., Aubry, J., Paris, F., Birkle, S.: Cell cycle arrest and apoptosis induced by O-acetyl-GD2-specific monoclonal antibody 8B6 inhibits tumor growth in vitro and in vivo. Cancer Lett. 333(2), 194–204 (2013). https://doi.org/10.1016/j.canlet.2013.01.032

    Article  CAS  PubMed  Google Scholar 

  34. Cheresh, D.A., Pierschbacher, M.D., Herzig, M.A., Mujoo, K.: Disialogangliosides GD2 and GD3 are involved in the attachment of human melanoma and neuroblastoma cells to extracellular matrix proteins. J. Cell Biol. 102(3), 688–696 (1986)

    Article  CAS  PubMed  Google Scholar 

  35. Kohla, G., Stockfleth, E., Schauer, R.: Gangliosides with O-acetylated sialic acids in tumors of neuroectodermal origin. Neurochem. Res. 27(7–8), 583–592 (2002)

    Article  CAS  PubMed  Google Scholar 

  36. Furukawa, K., Aixinjueluo, W., Kasama, T., Ohkawa, Y., Yoshihara, M., Ohmi, Y., Tajima, O., Suzumura, A., Kittaka, D., Furukawa, K.: Disruption of GM2/GD2 synthase gene resulted in overt expression of 9-O-acetyl GD3 irrespective of Tis21. J. Neurochem. 105(3), 1057–1066 (2008). https://doi.org/10.1111/j.1471-4159.2008.05232.x

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Fuller, M., Duplock, S., Hein, L.K., Rigat, B.A., Mahuran, D.J.: Liquid chromatography/electrospray ionisation-tandem mass spectrometry quantification of GM2 gangliosides in human peripheral cells and plasma. Anal. Biochem. 458, 20–26 (2014). https://doi.org/10.1016/j.ab.2014.04.018

    Article  CAS  PubMed  Google Scholar 

  38. Barrientos, R.C., Zhang, Q.: Isobaric labeling of intact gangliosides toward multiplexed LC-MS/MS-based quantitative analysis. Anal. Chem. 90(4), 2578–2586 (2018). https://doi.org/10.1021/acs.analchem.7b04044

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Sjoberg, E.R., Manzi, A.E., Khoo, K.H., Dell, A., Varki, A.: Structural and immunological characterization of O-acetylated GD2. Evidence that GD2 is an acceptor for ganglioside O-acetyltransferase in human melanoma cells. J. Biol. Chem. 267(23), 16200–16211 (1992)

    CAS  PubMed  Google Scholar 

  40. Ren, S., Ariga, T., Scarsdale, J.N., Zhang, Y., Slominski, A., Livingston, P.O., Ritter, G., Kushi, Y.: Yu, R.K.: characterization of a hamster melanoma-associated ganglioside antigen as 7-O-acetylated disialoganglioside GD3. J. Lipid Res. 34(9), 1565–1572 (1993)

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

We thank Christian Slomianny of the BICeL-Campus Lille1 (Univ. Lille, Bio Imaging Center Lille, F-59000 Lille, France) facility for access to instruments and technical advices. We are indebted to the PAGés plateform (Plateforme d’Analyses des Glycoconjugués, CNRS, UMR 8576, UGSF, Université de Lille), F-59000 Lille, France for the use of the mass spectrometer.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sophie Groux-Degroote.

Ethics declarations

Conflicts of interest

The authors declare that they have no conflicts of interest.

Ethical approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cavdarli, S., Dewald, J.H., Yamakawa, N. et al. Identification of 9-O-acetyl-N-acetylneuraminic acid (Neu5,9Ac2) as main O-acetylated sialic acid species of GD2 in breast cancer cells. Glycoconj J 36, 79–90 (2019). https://doi.org/10.1007/s10719-018-09856-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10719-018-09856-w

Keywords

Navigation